A carregar...

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor

The use of antiplatelet agents, specifically the thienopyridines, has become a standard of care in the approach to the patient presenting with an acute coronary syndrome. These drugs irreversibly inhibit the platelet by permanently binding to the surface P2Y12 receptor and blocking the downstream fi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Birkeland, Kade, Parra, David, Rosenstein, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3262315/
https://ncbi.nlm.nih.gov/pubmed/22282698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S9650
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!